Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,000,731 | $4,259,328 | $4,253,370 | $3,968,986 |
| Dep. & Amort. | $875,243 | $929,437 | $743,828 | $676,992 |
| Deferred Tax | $0 | -$53,269 | -$8,246 | $2,859 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,027,925 | -$1,371,691 | $1,878,583 | $860,494 |
| Other Non-Cash | $594,378 | $339,819 | $123,295 | $167,025 |
| Operating Cash Flow | $3,442,427 | $4,103,625 | $6,999,076 | $5,673,497 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,128,144 | -$1,628,447 | -$1,383,874 | -$1,254,917 |
| Net Acquisitions | -$1,565 | $0 | -$1,900 | $31,173 |
| Inv. Purchases | -$6,545,978 | -$4,306,259 | -$6,917,975 | -$402,163 |
| Inv. Sales/Matur. | $1,709,380 | $2,421,450 | $899,460 | $687,501 |
| Other Inv. Act. | $2,361 | $398,397 | $151,100 | $6,837 |
| Investing Cash Flow | -$5,963,946 | -$3,114,859 | -$7,253,188 | -$931,569 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,563,486 | $226,288 | $1,273,738 | -$116,756 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2,250,715 | -$1,585,201 | -$1,116,918 | -$874,676 |
| Other Fin. Act. | -$318,992 | -$619,088 | $262,753 | -$111,167 |
| Financing Cash Flow | -$1,006,221 | -$1,978,001 | $45,950 | -$1,493,979 |
| Forex Effect | $7,136 | $8,080 | -$503 | $283 |
| Net Chg. in Cash | -$3,520,605 | -$981,155 | -$208,665 | $3,248,231 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,823,544 | $20,804,699 | $21,013,364 | $17,765,133 |
| End Cash | $16,302,939 | $19,823,544 | $20,804,699 | $21,013,364 |
| Free Cash Flow | $2,314,282 | $2,475,178 | $5,615,203 | $4,418,579 |